March 24, 2020

ElmediX wants to stop coronavirus by heating patients in a controlled manner

for BioVox

Mechelen, Belgium, 24 March 2020 – The coronavirus has brought the whole world to a standstill. The Belgian company ElmediX wants to contain the virus with intensive [...]

March 24, 2020

Professors of Product Development from UAntwerp are looking at emergency production of mouth masks

for BioVox

At the University of Antwerp, twelve product developers are working day and night to develop oral masks. “Together with industrial partners, we try to set up an [...]

March 24, 2020

The long-distance race for a corona vaccine

for BioVox

Developing a vaccine takes a long time and occurs in different phases. A virus spreads quickly and unpredictably. Therefore, the outcome is a gamble for anyone in the race for the corona vaccine.

March 24, 2020

Gates Foundation commissions large coronavirus study from KU Leuven

for BioVox

The Bill & Melinda Gates Foundation is to provide samples of 15,000 therapeutic molecules to the Gasthuisberg hospital at the University of Leuven, to aid research into therapies to combat the coronavirus COVID-19, De Standaard reports.

March 24, 2020

VIB achieves important milestone in the development of a COVID-19 drug

for BioVox

Earlier this year, the lab of Xavier Saelens (VIB-UGent) announced the discovery of a unique antibody that is capable of binding the virus that causes COVID-19 (SARS-CoV-2). [...]

February 26, 2020

Why everyone needs to be a part of the CRISPR conversation

for BioVox

With the soaring cost of drugs for rare indications, many biotech and pharmaceutical companies are focusing R&D efforts on orphan diseases. Will the pendulum swing back towards more common maladies?

February 26, 2020

Belgian initiatives boosting animal-free innovation

for BioVox

Animals have been used throughout history to understand human physiology and to resolve scientific questions related to health and disease. Nowadays, however, both scientists [...]

February 20, 2020

Montis Biosciences launched with €8.4 million seed financing and a novel approach to immuno-oncology

for BioVox

Montis Biosciences announces its launch with €8,4 million in seed financing from an international investor syndicate to investigate interactions between perivascular macrophages [...]

February 12, 2020

Inari: shaking things up in the agriculture business

by Amy LeBlanc
for BioVox

Inari Agriculture has been awarded the 2020 Newcomer of the Year Trophy by Flanders Investment & Trade (FIT). Inari (US) opened its first foreign R&D branch in Ghent’s biotech valley just over a year ago. Since then, the Belgian team has been hard at work developing plants that can address both growing global food requirements and climate change. They’re approaching the challenge with both the latest genetic techniques and with a fresh perspective on how a business should be run.

February 10, 2020

PharmaFluidics announces product range extension for its µPACᵀᴹ chromatography chips to serve new biopharma markets

for BioVox

Ghent, Belgium, February 10, 2020 - PharmaFluidics NV, an innovative player in the field of analytical chromatography, announces a product range extension into capillary flow rate liquid chromatography (capillary LC). PharmaFluidics initiates commercial supplies of its new µPAC™ capLC column, bringing unprecedented sensitivity, reproducibility and robustness to a new range of customers worldwide, including the biopharmaceutical industry. PharmaFluidics’ unique high-resolution µPAC™ micro-Chip technology enables separation and detection of individual compounds in complex biological samples such as biopsies, proteome digests, culture media or biopharmaceutical actives, with unmatched precision.

January 23, 2020

Could tick saliva help save lives?

for BioVox

January 22, 2020

Predictions for Belgian Biotech in 2020

by Amy LeBlanc
for BioVox

With the Belgian biotech landscape blooming, BioVox reached out to some of the investors in our network to see what their predictions are for the coming year. From trends to companies to keep an eye on, here’s their take on 2020!

January 22, 2020

Battling antibiotic resistance: new strategy targets bacterial slime

by Amy LeBlanc
for BioVox

Researchers have developed a new antibacterial strategy that weakens bacteria by preventing them from cooperating. The method involves attacking the protective biofilm produced by the whole bacterial colony, rather than the individual bacteria themselves. Because this results in non-resistant bacteria outcompeting their antibiotic resistant neighbors, the strategy does not promote the development of further resistance.

January 22, 2020

Signposts inspired by bat sonar improve self-driving robots

by Amy LeBlanc
for BioVox

To improve sonar navigation systems used by self-driving robots, researchers from Belgium, The Netherlands and Germany have turned to nature for an ingenious solution. By studying the relationship between bats and flowers, scientists found that the plants were reflecting a specific sonar signal to guide the bats. They used this concept to create artificial sonar signposts.

BioVox